A woman at a crossroads, deciding on a new direction
A woman at a crossroads, deciding on a new direction

Why it’s Time to Change the Prior Authorization Process

Read our new article in the May edition of the Benefits and Pensions Monitor magazine, where we explore the history of prior authorization, specialty drug spend, new technologies and solutions to advance prior authorization. Learn more about electronic completion and submission of prior authorization claims (ePA), what it looks like, and its role in the future of prior authorization.

Today, several provincial payers in Canada have already implemented ePA solutions. The U.S. private sector has also been active in the ePA landscape, with positive results from introducing ePA. Find out more about what ePA can look like for private stakeholders in Canada, and the benefits and advancements that ePA can bring.

“Electronic prior authorization shows promise to get the right medication to the right patient at the right time. When a patient is prescribed a tailored treatment option for a moderate to severe form of a disease, they have often dealt with lengthy waits to get a diagnosis and tried first- and second-line therapies that did not do the trick or eventually failed them. Administrative delays caused by outdated, manual, and paper-based processes add insult to injury. Electronic prior authorization is a creative solution that can get patients started on a new treatment, and hopefully, back to their lives.”

-Rachael Manion, Executive Director at the Canadian Skin Patient Alliance.

Related Blogs